Description
A PGE1 analog and agonist of EP2 and EP3 receptors; binds to EP1, EP2, EP3-III, and EP4 receptors (Kis = 35.675, 10.249, 0.319, 5.499 μM, respectively), and is selective for EP receptors over DP, FP, IP, and TP receptors (Kis = >100 μM for all); inhibits electrically induced twitch contraction in isolated guinea pig ileum circular muscle and vas deferens (EC50s = 102.92 and 4.3 nM, respectively), which endogenously express high levels of EP2 and EP3 receptors, respectively; inhibits FMLP-induced superoxide anion generation in human neutrophils (EC50 = 0.35 μM); inhibits ethanol-induced gastric lesion formation in rats (ED50 = 0.31 μg/kg)
Formal name: 9-oxo-11α,16-dihydroxy-16-methyl-prost-13E-en-1-oic acid, methyl ester
Synonyms: SC 29333
Molecular weight: 382.5
CAS: 59122-46-2
Purity: ≥98%
Formulation: A solution in methyl acetate
Product Type|Biochemicals|Lipids|Prostaglandins||Product Type|Biochemicals|Receptor Pharmacology|Agonists||Research Area|Immunology & Inflammation|Gastric Disease|Peptic Ulcers||Research Area|Immunology & Inflammation|Innate Immunity||Research Area|Lipid Biochemistry|Cyclooxygenase Pathway